Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease.
Nakamuta M, Fujino T, Yada R, Yada M, Yasutake K, Yoshimoto T, Harada N, Higuchi N, Kato M, Kohjima M, Taketomi A, Maehara Y, Nakashima M, Kotoh K, Enjoji M.
Nakamuta M, et al. Among authors: nakashima m.
Int J Mol Med. 2009 May;23(5):603-8. doi: 10.3892/ijmm_00000170.
Int J Mol Med. 2009.
PMID: 19360318